11. Cancer
Limitations of Cytotoxic Chemotherapy Narrow therapeutic index (tox cancer/tox normal cell 1) Primary resistance (some cancers never respond to drugs) Secondary resistance (most cancers become resistant after exposure to chemotherapy) Dose-limiting toxicities (can’t use higher doses due to lethality/morbidity of toxicities) Minimal residual disease Condition of the patient (health status, co-morbidities) Rationale for Combination Chemotherapy Partial or complete primary resistance is common, and emergence of secondary resistance upon exposure to one drug is rapid Multiple drugs given at once e
您可能关注的文档
最近下载
- 危险化学品运输安全管理方案.docx
- 山东各市近三年(2022-2024)中考化学真题分类汇编专题16物质的检验、鉴别与除杂、推断含详解.docx VIP
- 基坑临边防护方案.docx VIP
- 国企领导班子及个人2026年学习教育查摆问题清单(四大方面)两篇.docx VIP
- 无人机操作培训课程大纲.docx VIP
- Bosch Rexroth6000硬件,软件培训.pdf VIP
- 基于SolidWorks的篮球发球机的结构的设计.docx VIP
- 07FG01 防空地下室设计荷载及结构构造.docx VIP
- DAC360数控系统调试培训(DOC).docx VIP
- HG-T 2424-2012 硬脂酸钙-行业标准规范.pdf VIP
原创力文档

文档评论(0)